Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
4.09M
-
Shares change
-
-335K
-
Total reported value, excl. options
-
$6.1M
-
Value change
-
-$618K
-
Put/Call ratio
-
0.13
-
Number of buys
-
6
-
Number of sells
-
-9
-
Price
-
$1.49
Significant Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q3 2024
32 filings reported holding IMMX - Immix Biopharma, Inc. - Common Stock as of Q3 2024.
Immix Biopharma, Inc. - Common Stock (IMMX) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.09M shares
.
Largest 10 shareholders include AIGH Capital Management LLC (1.12M shares), Bleichroeder LP (850K shares), Cable Car Capital LLC (796K shares), VANGUARD GROUP INC (699K shares), GEODE CAPITAL MANAGEMENT, LLC (150K shares), MORGAN STANLEY (84.3K shares), Royal Bank of Canada (84K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (43.3K shares), STATE STREET CORP (43K shares), and NORTHERN TRUST CORP (38.9K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.